跳至主要内容
临床试验/NCT02435797
NCT02435797Unknown4 期

Effect of Early Administration of Intracoronary Nicorandil Via Thrombus Aspiration Catheter Device During Primary Percutaneous Coronary Intervention for the Patients of Acute ST Segment Elevation Myocardial Infarction

Xuzhou Central Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
试验地点
1
主要终点
Primary composite endpoint (whether premature beats,atrial or ventricular tachycardia, atrial or ventricular fibrillation, and atrioventricular block appears;whether severity of chest pain is aggravated,and number of episodes chest pain)

研究概览

简要总结

To evaluate whether nicorandil as an adjunctive therapy for acute myocardial infarction (AMI) reduces reperfusion injury.

详细描述

Reperfusion injury might occur in patients with acute ST segment elevation myocardial infarction undergoing the primary percutaneous coronary intervention(P-PCI),characterized by myocardial stunning, reperfusion-induced arrhythmia, microvascular dysfunction and myocardial cellular apoptosis, etc.

Nicorandil is an antianginal agent with a dual mechanism of action: nitrate and K+ATP channel opener. The nitrate action causes vasodilation of systemic veins and epicardial coronary arteries, while the adenosine triphosphate (ATP)-sensitive potassium channel opener action causes vasodilation of peripheral and coronary resistance arterioles. Nicorandil not only decreases preload and afterload but also increases coronary blood flow.

The study will compare the effectiveness between nicorandil and placebo of preventing the reperfusion injury and left ventricle remodeling in patients with acute ST segment elevation myocardial infarction undergoing the P-PCI.It is intended that before reperfusion injury ,nicorandil which was early used by intracoronary injection could prevent and release the microcirculatory spasm, release the coronary microvascular endothelial swelling,decrease embolism of atherosclerotic debris and thrombus formation.So,it could decrease the phenomenon of no-reflow/slow reflow,reperfusion-induced arrhythmia and worsening of chest pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Acute ST Segment Elevation Myocardial Infarction (ASTEMI) defined as typical chest pain lasting >30min within the previous 12 h, with a clear ST-segment elevation of >0.1millivolt(mV) in ≥2 contiguous electrocardiographic leads, and the value of troponin I(TNI) above the maximum peak in the normal range.
  • Age20-80,All genders
  • The first myocardial infarction, and there is no history of PCI therapy and coronary artery bypass grafting
  • The infarct-related artery(IRA) is totally occlusive
  • Blood pressure is higher than 90/60 millimeters of mercury(mmHg)
  • The time from myocardial infarction onset to reach the hospital is less than 12 hs
  • Successful interventional treatment, the residual stenosis of IRA is less than 30% ,
  • TIMI flow grade 3

排除标准

  • kidney dysfunction (creatinine >2 mg/dl),
  • History of previous liver disease,
  • Cardiogenic shock,
  • History of myocardial infarction (MI)
  • History of coronary artery bypass grafting
  • History of allergic response to drugs
  • Right ventricular infarction
  • Severe hypovolemia

研究组 & 干预措施

Nicorandil

Active Comparator

Nicorandil for injection

干预措施: Nicorandil (Drug)

normal saline

Placebo Comparator

normal saline

干预措施: normal saline (Drug)

结局指标

主要结局

Primary composite endpoint (whether premature beats,atrial or ventricular tachycardia, atrial or ventricular fibrillation, and atrioventricular block appears;whether severity of chest pain is aggravated,and number of episodes chest pain)

时间窗: 24hours

The primary composite endpoint consisted of reperfusion-induced arrhythmia, worsening of chest pain, and no-reflow/slow reflow. In perioperative period,we will observe whether the reperfusion-induced arrhythmia including atrial or ventricular premature beats,atrial or ventricular tachycardia, atrial or ventricular fibrillation, and atrioventricular block appears;whether the severity of chest pain is aggravated,and the number of episodes of chest pain will be recorded for patients who complains of chest pain that lasted for at least 30 min within the 24 h following onset of MI;Whether the phenomenon of no-reflow/slow reflow appears.No-reflow and slow flow are diagnosed when the thrombolysis in myocardial infarction(TIMI) flow grade is 2 or lower,despite successful PCI such as balloon angioplasty or stent insertion.

次要结局

  • the combined outcome of TIMI frame count (cTFC) of CAG and ST resolution (STR) of ECG(24hours)

研究者

发起方
Xuzhou Central Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Feng Chunguang

Associate Professor

Xuzhou Central Hospital

研究点 (1)

Loading locations...

相似试验